Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asim Roy

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Journal of Medical Economics|September 28, 2024
Cost-effectiveness of TOMAC therapy for medication-refractory restless legs syndrome: an updated analysis based on Extension study dataAnne M Ryschon, Asim Roy, Jan B Pietzsch
BMC Neurology|November 22, 2023
Adjunctive tonic motor activation enables opioid reduction for refractory restless legs syndrome: a prospective, open-label, single-arm clinical trialMark J Buchfuhrer, Asim Roy, Stephanye Rodriguez, et al.
Neurology and Therapy|October 12, 2023
Cost-Effectiveness of Tonic Motor Activation (TOMAC) Therapy for Patients with Restless Legs Syndrome: An Exploratory AnalysisAnne M Ryschon, Khoa N Cao, Asim Roy, et al.
Neurology and Therapy|April 25, 2024
Dosing Optimization of Low-Sodium Oxybate in Narcolepsy and Idiopathic Hypersomnia in Adults: Consensus RecommendationsAnne Marie Morse, Richard K Bogan, Asim Roy, et al.
Nature and Science of Sleep|October 6, 2023
Individualized Treatment Patterns for Patients with Narcolepsy Treated with Oxybate: A Clinical Practice PerspectiveAsim Roy, Diane Ito, Susan Morris, et al.
CNS Drugs|March 20, 2025
Assessing Early Efficacy After Initiation of Once-Nightly Sodium Oxybate (ON-SXB; FT218) in Participants with Narcolepsy Type 1 or 2: A Post Hoc Analysis from the Phase 3 REST-ON TrialLois Krahn, Asim Roy, John W Winkelman, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|April 23, 2024
Effectiveness and optimization of low-sodium oxybate in participants with narcolepsy switching from a high-sodium oxybate: data from the Substitution of Equal Grams of Uninterrupted Xyrem to Xywav studyWayne Macfadden, Eileen B Leary, Douglas S Fuller, et al.
Frontiers in Psychology|August 24, 2018
Editorial: Representation in the BrainAsim Roy, Leonid Perlovsky, Tarek R Besold, et al.
Clinical Therapeutics|August 17, 2024
Weight Loss With Once-nightly Sodium Oxybate for the Treatment of Narcolepsy: Analysis From the Phase III Randomized study Evaluating the efficacy and SafeTy of a ONce nightly formulation of sodium oxybate (REST-ON) TrialThomas Roth, Anne Marie Morse, Richard Bogan, et al.
Small (Weinheim an Der Bergstrasse, Germany)|April 19, 2024
Unraveling the Role of 2D Ti<sub>3</sub>C<sub>2</sub>T<sub>x</sub> MXene Nanosheets in Cu-Based Double Perovskite Active Layer for Enhanced Photovoltaic PerformanceAnurag Dehingia, Ujjal Das, Himadri Priya Gogoi, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Journal of Medical Economics|September 28, 2024
Cost-effectiveness of TOMAC therapy for medication-refractory restless legs syndrome: an updated analysis based on Extension study dataAnne M Ryschon, Asim Roy, Jan B Pietzsch
BMC Neurology|November 22, 2023
Adjunctive tonic motor activation enables opioid reduction for refractory restless legs syndrome: a prospective, open-label, single-arm clinical trialMark J Buchfuhrer, Asim Roy, Stephanye Rodriguez, et al.
Neurology and Therapy|October 12, 2023
Cost-Effectiveness of Tonic Motor Activation (TOMAC) Therapy for Patients with Restless Legs Syndrome: An Exploratory AnalysisAnne M Ryschon, Khoa N Cao, Asim Roy, et al.
Neurology and Therapy|April 25, 2024
Dosing Optimization of Low-Sodium Oxybate in Narcolepsy and Idiopathic Hypersomnia in Adults: Consensus RecommendationsAnne Marie Morse, Richard K Bogan, Asim Roy, et al.
Nature and Science of Sleep|October 6, 2023
Individualized Treatment Patterns for Patients with Narcolepsy Treated with Oxybate: A Clinical Practice PerspectiveAsim Roy, Diane Ito, Susan Morris, et al.
CNS Drugs|March 20, 2025
Assessing Early Efficacy After Initiation of Once-Nightly Sodium Oxybate (ON-SXB; FT218) in Participants with Narcolepsy Type 1 or 2: A Post Hoc Analysis from the Phase 3 REST-ON TrialLois Krahn, Asim Roy, John W Winkelman, et al.
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|April 23, 2024
Effectiveness and optimization of low-sodium oxybate in participants with narcolepsy switching from a high-sodium oxybate: data from the Substitution of Equal Grams of Uninterrupted Xyrem to Xywav studyWayne Macfadden, Eileen B Leary, Douglas S Fuller, et al.
Frontiers in Psychology|August 24, 2018
Editorial: Representation in the BrainAsim Roy, Leonid Perlovsky, Tarek R Besold, et al.
Clinical Therapeutics|August 17, 2024
Weight Loss With Once-nightly Sodium Oxybate for the Treatment of Narcolepsy: Analysis From the Phase III Randomized study Evaluating the efficacy and SafeTy of a ONce nightly formulation of sodium oxybate (REST-ON) TrialThomas Roth, Anne Marie Morse, Richard Bogan, et al.
Small (Weinheim an Der Bergstrasse, Germany)|April 19, 2024
Unraveling the Role of 2D Ti<sub>3</sub>C<sub>2</sub>T<sub>x</sub> MXene Nanosheets in Cu-Based Double Perovskite Active Layer for Enhanced Photovoltaic PerformanceAnurag Dehingia, Ujjal Das, Himadri Priya Gogoi, et al.
Pageof 4